Publications from Clinical Neurophysiology

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial

Piehl, Fredrik; Eriksson-Dufva, Ann; Budzianowska, Anna; Feresiadou, Amalia et al.

Part of JAMA Neurology, p. 1105-1112, 2022.

DOI for Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial

Enrichment of serum IgG4 in MuSK myasthenia gravis patients

Vergoossen, Dana L. E.; Ruiter, Annabel M.; Keene, Kevin R.; Niks, Erik H. et al.

Part of Journal of Neuroimmunology, 2022.

DOI for Enrichment of serum IgG4 in MuSK myasthenia gravis patients Download full text (pdf) of Enrichment of serum IgG4 in MuSK myasthenia gravis patients

Ultrathin Gold Microelectrode Array using Polyelectrolyte Multilayers for Flexible and Transparent Electro-Optical Neural Interfaces

Hong, Woongki; Lee, Jee Woong; Kim, Duhee; Hwang, Yujin et al.

Part of Advanced Functional Materials, 2022.

DOI for Ultrathin Gold Microelectrode Array using Polyelectrolyte Multilayers for Flexible and Transparent Electro-Optical Neural Interfaces

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Rostedt Punga, Anna; Maddison, Paul; Heckmann, Jeannine M.; Guptill, Jeffrey et al.

Part of Lancet Neurology, p. 176-188, 2022.

DOI for Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

Beretta, Francesca; Huang, Yu-Fang; Rostedt Punga, Anna

Part of Cells, 2022.

DOI for Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p Download full text (pdf) of Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report

Ehrstedt, Christoffer; Liu, Wei-Wei; Frykholm, Carina; Beeson, David et al.

Part of Neuromuscular Disorders, p. 80-83, 2022.

DOI for Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report Download full text (pdf) of Novel pathogenic ALG2 mutation causing congenital myasthenic syndrome: A case report

Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study

Verwijst, Johanna; Westerberg, Elisabet; Rostedt Punga, Anna

Part of European Journal of Neurology, p. 1706-1715, 2021.

DOI for Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study Download full text (pdf) of Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study

Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

Frithiof, Robert; Rostami, Elham; Kumlien, Eva; Virhammar, Johan et al.

Part of Clinical Neurophysiology, p. 1733-1740, 2021.

DOI for Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study Download full text (pdf) of Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study

Epidemiology of Myasthenia Gravis in Sweden 2006-2016

Westerberg, Elisabet; Rostedt Punga, Anna

Part of Brain and Behavior, 2020.

DOI for Epidemiology of Myasthenia Gravis in Sweden 2006-2016 Download full text (pdf) of Epidemiology of Myasthenia Gravis in Sweden 2006-2016

Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation

Rostedt Punga, Anna; Liik, Maarika

Part of Clinical Neurophysiology Practice, p. 46-49, 2020.

DOI for Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation Download full text (pdf) of Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation

Mortality rates and causes of death in Swedish Myasthenia Gravis patients

Westerberg, Elisabet; Rostedt Punga, Anna

Part of Neuromuscular Disorders, p. 815-824, 2020.

DOI for Mortality rates and causes of death in Swedish Myasthenia Gravis patients Download full text (pdf) of Mortality rates and causes of death in Swedish Myasthenia Gravis patients

Myasthenia gravis patient and physician opinions about immunosuppressant reduction

Hehir, Michael K.; Rostedt Punga, Anna; Ciafaloni, Emma

Part of Muscle and Nerve, p. 767-772, 2020.

DOI for Myasthenia gravis patient and physician opinions about immunosuppressant reduction

Myasthenia Gravis and Physical Exercise: A Novel Paradigm

O'Connor, Laura; Westerberg, Elisabet; Rostedt Punga, Anna

Part of Frontiers in Neurology, 2020.

DOI for Myasthenia Gravis and Physical Exercise: A Novel Paradigm Download full text (pdf) of Myasthenia Gravis and Physical Exercise: A Novel Paradigm

Flodvåg av långtidssjuka covid-19-patienter väntar

Rostedt Punga, Anna; Strömme, Maria; Alimohammadi, Mohammed; Eltahir, Mohammed et al.

Part of Dagens Nyheter, p. 5-5, 2020.

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs

Fiorillo, Alyson A.; Heier, Christopher R.; Huang, Yu-Fang; Tully, Christopher B. et al.

Part of Frontiers in Immunology, 2020.

DOI for Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs Download full text (pdf) of Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

Sabre, Liis; Punga, Tanel; Rostedt Punga, Anna

Part of Frontiers in Immunology, 2020.

DOI for Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine Download full text (pdf) of Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27

Bogatikov, Evgenii; Lindblad, Ida; Punga, Tanel; Rostedt Punga, Anna

Part of Neuroscience research, p. 46-52, 2020.

DOI for miR-1933-3p is upregulated in skeletal muscles of MuSK+ EAMG mice and affects Impa1 and Mrpl27

Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients

O'Connor, Laura; Westerberg, Elisabet; Rostedt Punga, Anna

Part of JOURNAL OF NEUROMUSCULAR DISEASES, p. 85-91, 2019.

DOI for Pattern of Habitual Physical Exercise in Myasthenia Gravis Patients

Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)

Pazarlis, Konstantinos A.; Rostedt Punga, Anna; Schizas, Nikos; Sandén, Bengt et al.

Part of BMJ Open, 2019.

DOI for Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten) Download full text (pdf) of Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)

Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis

Sabre, Liis; Evoli, Amelia; Rostedt Punga, Anna

Part of Journal of the Neurological Sciences, p. 15-21, 2019.

DOI for Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis

Facing the challenges of electrodiagnostic studies in the very elderly (>80 years) population

Rostedt Punga, Anna; Jabre, Joe F.; Amandusson, Åsa

Part of Clinical Neurophysiology, p. 1091-1097, 2019.

DOI for Facing the challenges of electrodiagnostic studies in the very elderly (>80 years) population

miR-30e-5p as predictor of generalization in ocular myasthenia gravis

Sabre, Liis; Maddison, Paul; Wong, Sui H.; Sadalage, Girija et al.

Part of Annals of clinical and translational neurology, p. 243-251, 2019.

DOI for miR-30e-5p as predictor of generalization in ocular myasthenia gravis Download full text (pdf) of miR-30e-5p as predictor of generalization in ocular myasthenia gravis

Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

Bränn, Emma; Edvinsson, Åsa; Rostedt Punga, Anna; Sundström Poromaa, Inger et al.

Part of Scientific Reports, 2019.

DOI for Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum Download full text (pdf) of Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

Circulating microRNA plasma profile in MuSK plus myasthenia gravis

Sabre, Liis; Guptill, Jeffrey T.; Russo, Melissa; Juel, Vern C. et al.

Part of Journal of Neuroimmunology, p. 87-91, 2018.

DOI for Circulating microRNA plasma profile in MuSK plus myasthenia gravis

Advances in autoimmune myasthenia gravis management

Wang, Shuhui; Breskovska, Iva; Gandhy, Shreya; Rostedt Punga, Anna et al.

Part of Expert Review of Neurotherapeutics, p. 573-588, 2018.

DOI for Advances in autoimmune myasthenia gravis management

Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology

Lewandowska, Marta; Bogatikov, Evgenii; Hierlemann, Andreas R.; Rostedt Punga, Anna

Part of Frontiers in Physiology, 2018.

DOI for Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology Download full text (pdf) of Long-Term High-Density Extracellular Recordings Enable Studies of Muscle Cell Physiology

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

Sabre, Liis; Maddison, Paul; Sadalage, Girija; Ambrose, Philip Alexander et al.

Part of Journal of Neuroimmunology, p. 164-170, 2018.

DOI for Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis Download full text (pdf) of Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis

Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis

Westerberg, Elisabet; Landtblom, Anne-Marie; Rostedt Punga, Anna

Part of Acta Neurologica Scandinavica, p. 557-565, 2018.

DOI for Lifestyle factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis

Thymectomy lowers the myasthenia gravis biomarker miR-150-5p

Molin, Carl Johan; Sabre, Liis; Weis, Cleo-Aron; Punga, Tanel et al.

Part of Neurology, 2018.

DOI for Thymectomy lowers the myasthenia gravis biomarker miR-150-5p Download full text (pdf) of Thymectomy lowers the myasthenia gravis biomarker miR-150-5p

The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study

Westerberg, Elisabet; Molin, Carl Johan; Spörndly-Nees, Søren; Widenfalk, Johan et al.

Part of Medicine, 2018.

DOI for The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study Download full text (pdf) of The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study

Circulating microRNAs as potential biomarkers in myasthenia gravis patients.

Rostedt Punga, Anna; Punga, Tanel

Part of Annals of the New York Academy of Sciences, p. 33-40, 2018.

DOI for Circulating microRNAs as potential biomarkers in myasthenia gravis patients.

High-resistance strength training does not affect nerve cross sectional area – An ultrasound study

Molin, Carl Johan; Widenfalk, Johan; Rostedt Punga, Anna

Part of Clinical Neurophysiology Practice, p. 163-169, 2017.

DOI for High-resistance strength training does not affect nerve cross sectional area – An ultrasound study Download full text (pdf) of High-resistance strength training does not affect nerve cross sectional area – An ultrasound study

Diagnostic Utility of Repetitive Nerve Stimulation in a Large Cohort of Patients With Myasthenia Gravis

Amandusson, Åsa; Elf, Kristin; Grindlund, Margareta E; Punga, Anna R.

Part of Journal of clinical neurophysiology, p. 400-407, 2017.

DOI for Diagnostic Utility of Repetitive Nerve Stimulation in a Large Cohort of Patients With Myasthenia Gravis

Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations

Alimohammadi, Mohammed; Rostedt Punga, Anna

Part of Toxins, 2017.

DOI for Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations Download full text (pdf) of Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations

Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries

Sabre, Liis; Westerberg, Elisabet; Liik, Maarika; Punga, Anna R.

Part of Brain and Behavior, 2017.

DOI for Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries Download full text (pdf) of Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries

Physical exercise in Myasthenia Gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study

Westerberg, Elisabet; Molin, Carl Johan; Lindblad, Ida; Emtner, Margareta et al.

Part of Muscle and Nerve, p. 207-214, 2017.

DOI for Physical exercise in Myasthenia Gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Molin, Carl Johan; Westerberg, Elisabet; Rostedt Punga, Anna

Part of Scientific Reports, 2017.

DOI for Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients. Download full text (pdf) of Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis

Liik, Maarika; Rostedt Punga, Anna

Part of Clinical Neurophysiology, p. 3480-3484, 2016.

DOI for Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis

A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

Punga, Anna Rostedt; Alimohammadi, Mohammad; Fagrell, Dan; Nyberg, Frida et al.

Part of Dermatologic Surgery, p. 967-976, 2016.

DOI for A Randomized, Comparative Study to Evaluate Efficacy and Safety of Two Injection Volumes of AbobotulinumtoxinA in Treatment of Glabellar Lines

Compound Motor Action Potential: Electrophysiological Marker for Muscle Training

Molin, Carl Johan; Punga, Anna R.

Part of Journal of clinical neurophysiology, p. 340-345, 2016.

DOI for Compound Motor Action Potential: Electrophysiological Marker for Muscle Training

Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece

Chroni, Elisabeth; Dimisianos, Nikolaos; Punga, Anna Rostedt

Part of Acta Neurologica Belgica, p. 57-63, 2016.

DOI for Low vitamin D levels in healthy controls and patients with autoimmune neuromuscular disorders in Greece

Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.

Punga, Tanel; Bartoccioni, Emanuela; Lewandowska, Marta; Damato, Valentina et al.

Part of Journal of Neuroimmunology, p. 21-26, 2016.

DOI for Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis. Download full text (pdf) of Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.

Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design

Punga, Anna Rostedt; Eriksson, Annika; Alimohammadi, Mohammad

Part of Acta Dermato-Venereologica, p. 948-951, 2015.

DOI for Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design Download full text (pdf) of Regional Diffusion of Botulinum Toxin in Facial Muscles: A Randomised Double-blind Study and a Consideration for Clinical Studies with Split-face Design

Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients

Punga, Anna Rostedt; Andersson, Mats; Alimohammadi, Mohammad; Punga, Tanel

Part of Journal of the Neurological Sciences, p. 90-96, 2015.

DOI for Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients Download full text (pdf) of Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis

Phillips, W D; Christadoss, P; Losen, M; Punga, Anna Rostedt et al.

Part of Experimental Neurology, p. 29-40, 2015.

DOI for Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis

How clinical trials of myasthenia gravis can inform pre-clinical drug development

Rostedt Punga, Anna; Kaminski, Henry J; Richman, David P; Benatar, Michael

Part of Experimental Neurology, p. 78-81, 2015.

DOI for How clinical trials of myasthenia gravis can inform pre-clinical drug development

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

Punga, Tanel; Le Panse, Rozen; Andersson, Mats; Truffault, Frédérique et al.

Part of Annals of clinical and translational neurology, p. 49-58, 2014.

DOI for Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies

Elf, Kristin; Askmark, Håkan; Nygren, Ingela; Punga, Anna Rostedt

Part of Journal of the Neurological Sciences, p. 184-188, 2014.

DOI for Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies

Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles: A Double-blind, Placebo-controlled, Randomized Study

Alimohammadi, Mohammad; Andersson, Mats; Punga, Anna Rostedt

Part of Acta Dermato-Venereologica, p. 32-37, 2014.

DOI for Correlation of Botulinum Toxin Dose with Neurophysiological Parameters of Efficacy and Safety in the Glabellar Muscles: A Double-blind, Placebo-controlled, Randomized Study

Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK plus ) experimental autoimmune Myasthenia gravis (EAMG)

Chauhan, Mayank; Punga, Tanel; Punga, Anna Rostedt

Part of Neuroscience research, p. 102-109, 2013.

DOI for Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK plus ) experimental autoimmune Myasthenia gravis (EAMG)